BRIEF

on NOVACYT (EPA:ALNOV)

Successful VAT reclaim of £12.2 million by Novacyt

Stock price chart of NOVACYT (EPA:ALNOV) showing fluctuations.

Novacyt S.A. has successfully reclaimed £12.2 million in VAT from HMRC. This recovery comes after a request linked to Department of Health and Social Care (DHSC) invoices, which are no longer payable following a dispute settlement.

The company had previously announced this reclamation effort during its AGM on July 18, 2024. As part of the settlement, Novacyt paid £5.0 million to the DHSC in early July, resulting in a net cash position increase of over £7.0 million for the Group.

This announcement includes important information as per Article 7 of Regulation (EU) 596/2014. Novacyt, an international molecular diagnostics firm, continues to strengthen its financial position through strategic settlements and recoveries.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all NOVACYT news